| Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development F Baenke, B Peck, H Miess, A Schulze Disease models & mechanisms 6 (6), 1353-1363, 2013 | 849 | 2013 |
| Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma MR Girotti, G Gremel, R Lee, E Galvani, D Rothwell, A Viros, AK Mandal, ... Cancer discovery 6 (3), 286-299, 2016 | 236 | 2016 |
| Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 4 as an important regulator of prostate cancer cell survival S Ros, CR Santos, S Moco, F Baenke, G Kelly, M Howell, N Zamboni, ... Cancer discovery 2 (4), 328-343, 2012 | 225 | 2012 |
| Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy S Valpione, E Galvani, J Tweedy, PA Mundra, A Banyard, P Middlehurst, ... Nature cancer 1 (2), 210-221, 2020 | 173 | 2020 |
| Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells F Baenke, B Chaneton, M Smith, N Van Den Broek, K Hogan, H Tang, ... Molecular oncology 10 (1), 73-84, 2016 | 169 | 2016 |
| A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration K Yizhak, SE Le Dévédec, VM Rogkoti, F Baenke, VC De Boer, C Frezza, ... Molecular systems biology 10 (8), 744, 2014 | 163 | 2014 |
| Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma LD Trucco, PA Mundra, K Hogan, P Garcia-Martinez, A Viros, AK Mandal, ... Nature medicine 25 (2), 221-224, 2019 | 108 | 2019 |
| Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival F Baenke, S Dubuis, C Brault, B Weigelt, B Dankworth, B Griffiths, M Jiang, ... The Journal of pathology 237 (2), 152-165, 2015 | 99 | 2015 |
| Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer F Oehme, S Krahl, B Gyorffy, B Muessle, V Rao, H Greif, N Ziegler, K Lin, ... RNA biology 16 (10), 1339-1345, 2019 | 71 | 2019 |
| Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage response DD Vadysirisack, F Baenke, B Ory, K Lei, LW Ellisen Molecular and cellular biology, 2011 | 53 | 2011 |
| Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics S Dubuis, F Baenke, N Scherbichler, LT Alexander, A Schulze, ... Metabolic engineering 43, 173-186, 2017 | 36 | 2017 |
| Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma. Cancer Discov. 2016; 6: 286–299. doi: 10.1158/2159-8290 MR Girotti, G Gremel, R Lee, E Galvani, D Rothwell, A Viros, AK Mandal, ... CD-15-1336.[Abstract][CrossRef][Google Scholar], 0 | 36 | |
| Proteomic analyses of fibroblast-and serum-derived exosomes identify QSOX1 as a marker for non-invasive detection of colorectal cancer N Ganig, F Baenke, ML Thepkaysone, K Lin, VS Rao, FC Wong, H Polster, ... Cancers 13 (6), 1351, 2021 | 32 | 2021 |
| Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment A Hennig, F Baenke, A Klimova, S Drukewitz, B Jahnke, S Brückmann, ... The Journal of pathology 257 (5), 607-619, 2022 | 24 | 2022 |
| Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases VS Rao, Q Gu, S Tzschentke, K Lin, N Ganig, ML Thepkaysone, FC Wong, ... Oncogene 41 (12), 1809-1820, 2022 | 17 | 2022 |
| Expression of glypican 3 is an independent prognostic biomarker in primary gastro-esophageal adenocarcinoma and corresponding serum exosomes M Rahbari, M Pecqueux, D Aust, H Stephan, O Tiebel, A Chatzigeorgiou, ... Journal of clinical medicine 8 (5), 696, 2019 | 17 | 2019 |
| Comprehensive proteomic profiling of serum extracellular vesicles in patients with colorectal liver metastases identifies a signature for non-invasive risk stratification and … K Lin, F Baenke, X Lai, M Schneider, D Helm, H Polster, VS Rao, N Ganig, ... Molecular Cancer 21 (1), 91, 2022 | 11 | 2022 |
| Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech. 2013; 6: 1353–63 F Baenke, B Peck, H Miess, A Schulze | 10 | |
| New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology B Derraz, G Breda, C Kaempf, F Baenke, F Cotte, K Reiche, U Köhl, ... NPJ Precision Oncology 8 (1), 23, 2024 | 6 | 2024 |
| Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold T Schmäche, J Fohgrub, A Klimova, K Laaber, S Drukewitz, F Merboth, ... Molecular Cancer 23 (1), 10, 2024 | 4 | 2024 |
Almut SchulzeGerman Cancer Research Center在 dkfz-heidelberg.de 的电子邮件经过验证
